Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Bispecific Antibody
October 22, 2023
Antibody Drug Conjugates Bispecific Antibodies and Lung Cancer
Dr. C H Weaver MD
September 23, 2023
Bispecific Antibodies in Multiple Myeloma
Dr. C H Weaver MD
August 28, 2023
Elranatamab in Multiple Myeloma
Dr. C H Weaver MD
June 23, 2023
BI 764532 Bispecific Antibody for DLL3 Small Cell Lung Cancer
Dr. C H Weaver MD
June 10, 2023
Bispecific Antibody Promising in EGFR Expressing NSCLC
Dr. C H Weaver MD
December 8, 2020
Tecvayli (Teclistamab) for the Treatment of Multiple Myeloma
Dr. C H Weaver MD
December 8, 2020
Bispecific Antibody Precision Immunotherapy in Non-Hodgkin Lymphoma
Dr. C H Weaver MD
December 4, 2020
Treatment of Recurrent Multiple Myeloma
Dr. C H Weaver MD
December 4, 2020
Relapsed-Refractory Aggressive Non Hodgkins Lymphoma
Dr. C H Weaver MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
